General Biologicals Corporation (TPEX:4117)

General Biologicals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	739	1,274	1,615	1,609	2,082	3,231
Market Cap Growth	-32.87%	-21.11%	0.37%	-22.70%	-35.56%	609.23%
Enterprise Value	3,058	2,957	1,885	1,528	2,168	3,260
Last Close Price	12.15	20.26	26.11	26.01	33.65	52.21
PE Ratio	-	-	-	-	47.16	51.98
PS Ratio	2.94	5.06	6.10	4.34	3.77	6.79
PB Ratio	4.71	4.45	3.25	2.32	2.83	4.70
P/TBV Ratio	7.12	5.53	3.69	2.56	3.13	5.19
P/FCF Ratio	-	-	-	-	85.87	137.56
P/OCF Ratio	-	-	7.16	7.15	53.42	69.11
EV/Sales Ratio	12.16	11.74	7.12	4.13	3.93	6.85
EV/EBITDA Ratio	-	-	-	-	33.38	51.37
EV/EBIT Ratio	-	-	-	-	49.51	75.18
EV/FCF Ratio	-4.76	-	-	-	89.43	138.82
Debt / Equity Ratio	16.02	8.06	1.10	0.68	0.61	0.09
Debt / EBITDA Ratio	-	-	-	-	5.71	0.92
Debt / FCF Ratio	-	-	-	-	18.54	2.76
Net Debt / Equity Ratio	14.78	7.18	0.67	0.17	0.11	-0.59
Net Debt / EBITDA Ratio	-12.68	-10.54	-2.20	-5.19	1.24	-6.44
Net Debt / FCF Ratio	-3.61	-1.24	-1.67	-5.03	3.33	-17.41
Asset Turnover	0.08	0.09	0.13	0.26	0.53	0.85
Inventory Turnover	2.72	3.43	2.00	2.01	3.69	4.86
Quick Ratio	0.90	0.78	0.29	4.21	5.40	6.24
Current Ratio	1.32	0.99	0.39	5.62	6.62	7.13
Return on Equity (ROE)	-87.72%	-56.65%	-33.60%	-7.54%	6.20%	16.35%
Return on Assets (ROA)	-4.10%	-4.54%	-5.20%	-1.81%	2.61%	4.86%
Return on Capital Employed (ROCE)	-6.80%	-7.30%	-11.30%	-2.80%	3.70%	5.80%
Earnings Yield	-32.96%	-17.33%	-12.31%	-3.31%	2.12%	1.92%
FCF Yield	-87.00%	-130.36%	-12.28%	-1.46%	1.17%	0.73%
Buyback Yield / Dilution	-	-	-	0.14%	-13.44%	-33.78%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.